Shenyang Sinqi Pharmaceutical Co.,Ltd. is a state-level high-tech enterprise professionally engaged in ophthalmic R&D, production and sales. With the responsibility of revitalizing the Chinese national medical industry, Sinqi is wholeheartedly committed to the specialty of ophthalmology. In 2007, Sinqi Pharmaceutical R&D Center was named after the “Liaoning Sinqi Pharmaceutical Engineering and Technological ResearchCenter” by Liaoning Science and Technology Bureau. In 2014, Sinqi Pharmaceutical smoothly passed the 2010 national GMP certification.
“While forging ahead with determination and daring to struggle”, “Sinqi” has already become a successful ophthalmic brand through its unremitting efforts and innovation made by all Sinqi staff. Sinqi Pharmaceutical is marching towards the leading ophthalmic field with great concentration and persistence, transferring more scientific research achievements into superior products to serve public health and become a competitive brand across the world. At present, the company possesses ten series of more than 30 products such as antibacterial drugs, anti-inflammatory agents,artificial tears, cornea repair drugs, antiviral agents, anti-allergic drugs,antifungal drugs, mydriatic drugs, operation drugs, glaucoma curatives, etc. It has developed 6 original research drugs and 9 patent drugs so as to offer high-quality products to the curative field of ophthalmic diseases.
Founded in July 2009, the Sinqi Philanthropic Foundation was created with contributive capital of RMB 1 million by Newsun, Chairman and General Manager of the company. Along with its predecessor, the Sinqi Sunshine Foundation, the Sinqi Philanthropic Foundation signifies new progress that the company has made towards philanthropic reliefaction, and symbolizes Sinqi staff’s determination and confidence inshouldering social responsibilities.
Whilelooking into the future, opportunities co-exist with challenges. Theever-changing Sinqi Pharmaceutical maintains its development and expansion while adhering to the philosophy of “working exquisitely and giving back to thecountry with industry”, and strives to become a competitive ophthalmic research and manufacturing enterprise. Sinqi’s staff will continuously struggle to make greater contributions to boosting the progress of human ophthalmology!